While we have shown that activation of typical inflammatory pathways such those of NFκB and AP1 do not appear to be altered in a QS-ON infection, we are limited by the scope of our post-translational medication scan, which only measured phosphorylated proteins. This evidence concerns the gene NFKB1 and infection.